1. Home
  2. GFL vs UTHR Comparison

GFL vs UTHR Comparison

Compare GFL & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFL
  • UTHR
  • Stock Information
  • Founded
  • GFL 2007
  • UTHR 1996
  • Country
  • GFL Canada
  • UTHR United States
  • Employees
  • GFL 20000
  • UTHR N/A
  • Industry
  • GFL
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFL
  • UTHR Health Care
  • Exchange
  • GFL Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • GFL 18.4B
  • UTHR 16.1B
  • IPO Year
  • GFL 2020
  • UTHR 1999
  • Fundamental
  • Price
  • GFL $46.86
  • UTHR $315.91
  • Analyst Decision
  • GFL Strong Buy
  • UTHR Buy
  • Analyst Count
  • GFL 9
  • UTHR 12
  • Target Price
  • GFL $49.78
  • UTHR $388.25
  • AVG Volume (30 Days)
  • GFL 1.9M
  • UTHR 603.8K
  • Earning Date
  • GFL 04-30-2025
  • UTHR 04-30-2025
  • Dividend Yield
  • GFL 0.12%
  • UTHR N/A
  • EPS Growth
  • GFL N/A
  • UTHR 24.38
  • EPS
  • GFL N/A
  • UTHR 24.64
  • Revenue
  • GFL $5,464,123,877.00
  • UTHR $2,877,400,000.00
  • Revenue This Year
  • GFL N/A
  • UTHR $12.53
  • Revenue Next Year
  • GFL $6.28
  • UTHR $6.52
  • P/E Ratio
  • GFL N/A
  • UTHR $12.82
  • Revenue Growth
  • GFL 4.61
  • UTHR 23.63
  • 52 Week Low
  • GFL $30.57
  • UTHR $221.53
  • 52 Week High
  • GFL $48.87
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • GFL 56.75
  • UTHR 34.44
  • Support Level
  • GFL $45.46
  • UTHR $305.00
  • Resistance Level
  • GFL $48.09
  • UTHR $383.51
  • Average True Range (ATR)
  • GFL 1.62
  • UTHR 12.87
  • MACD
  • GFL 0.10
  • UTHR -4.32
  • Stochastic Oscillator
  • GFL 76.30
  • UTHR 13.90

About GFL GFL Environmental Inc. Subordinate voting shares no par value

GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Share on Social Networks: